Compare DHT Holdings Inc. (DHT) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DHT Holdings Inc. vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? DHT Holdings Inc. trades at $24.85 (market cap $4.02B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 14.6× DHT Holdings Inc.'s market cap, and DHT Holdings Inc. pays the higher dividend (19.57%). Which is the better fit depends on your goals — on Pluang, investors hold DHT Holdings Inc. for 0 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| DHT | TAK | |
|---|---|---|
Market Cap | $4.02B | $58.74B |
Volume | 5,493,801 | 3,110,994 |
Sector | Industrials | Health |
52-Week High | $24.93 | $19.05 |
52-Week Low | $11.20 | $13.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.29B | $86.65B |
Dividend Yield | 19.57% | 3.33% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DHT Holdings Inc.
DHT Holdings operates a fleet of crude oil tankers that trade on international routes. Its fleet consists of very large crude carriers, or VLCCs.
Read more on DHT →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
